Interrogating G-quadruplex (G4) biology at its deepest roots in human cells relies on the design, synthesis, and use of ever smarter molecular tools. Here, we demonstrate the versatility of biomimetic G4 ligands referred to as TASQ (template assembled synthetic G-quartet) in which a biotin handle was incorporated for G4-focused chemical biology investigations. We have rethought the biotinylated TASQ design to make it readily chemically accessible via an efficient click-chemistry-based strategy. The resulting biotinylated, triazole-assembled TASQ, or BioTriazoTASQ, was thus shown to efficiently isolate both DNA and RNA G4s from solution by affinity purification protocols, for identification purposes. Its versatility was then further demonstrated by optical imaging that provided unique mechanistic insights into the actual strategic relevance of G4-targeting strategies, showing that ligand-stabilized G4 sites colocalize with and, thus, are responsible for DNA damage foci in human cells.
Interrogating G-quadruplex (G4) biology at its deepest roots in human cells relies on the design, synthesis, and use of ever smarter molecular tools. Here, we demonstrate the versatility of biomimetic G4 ligands referred to as TASQ (template assembled synthetic G-quartet) in which a biotin handle was incorporated for G4-focused chemical biology investigations. We have rethought the biotinylated TASQ design to make it readily chemically accessible via an efficient click-chemistry-based strategy. The resulting biotinylated, triazole-assembled TASQ, or BioTriazoTASQ, was thus shown to efficiently isolate both DNA and RNA G4s from solution by affinity purification protocols, for identification purposes. Its versatility was then further demonstrated by optical imaging that provided unique mechanistic insights into the actual strategic relevance of G4-targeting strategies, showing that ligand-stabilized G4 sites colocalize with and, thus, are responsible for DNA damage foci in human cells.
The synthesis
of molecular tools
to interrogate G-quadruplex (G4) biology in human cells is an active
field of research.[1] Biotinylated probes
occupy a central position in chemical biology, as their biotin handle
allows for easy isolation of their cellular partners via ad
hoc avidin-based purification protocols.[2] It is therefore not surprising that biotinylated G4 ligands
were soon developed as molecular bait to fish out and identify G4s
from human cells: a biotinylated pyridostatin (PDS) was used to pull
down telomeric G4s from human fibrosarcoma HT1080 cells prior to their
identification by qPCR.[3] A biotinylated
pyridodicarboxamide (PDC) was used for in vitro selection
of G4-forming sequences (among others) within a library of 80 DNA
aptamers by SELEX (systematic evolution of ligands by exponential
enrichment).[4] This compound also enabled
visualization of G4 folding in DNA origami by atomic force microscopy.[5] More recently, a biotinylated perylene diimide
(PDI) was used to fish synthetic G4s out of oligonucleotide mixtures
in solution.[6]In these examples,
PDS, PDC, and PDI were selected for their established
affinity and selectivity for G4s and then chemically modified with
a biotin appendage. We recently reported on a complementary approach
based on the modification of template-assembled synthetic G-quartets
(TASQs).[7,8] The structure of these G4 ligands comprises
four guanines (Gs) that can assemble into an intramolecular G-quartet
(Figure A,B). This
synthetic quartet is then prone to interact with the external G-quartet
of G4s (a “native” G-quartet) according to a biomimetic,
like-likes-like interaction.[9] TASQs are
smart ligands as their G-quartet is only assembled upon interaction
with G4s, which makes them uniquely actively selective for their targets.[10] The first biotinylated
TASQ, named BioTASQ,[11−13] was used to selectively isolate (or pull down) G4s
from cell lysates before their identification by qPCR and sequencing.
Figure 1
(A) Chemical
structure of BioTASQ and BioCyTASQ. (B) Schematic
representation of the open and closed conformation of BioTASQ. (C)
Chemical synthesis of TriazoTASQ and BioTriazoTASQ (see the Supporting Information for details).
(A) Chemical
structure of BioTASQ and BioCyTASQ. (B) Schematic
representation of the open and closed conformation of BioTASQ. (C)
Chemical synthesis of TriazoTASQ and BioTriazoTASQ (see the Supporting Information for details).We improved the tedious chemical access to BioTASQ in designing
BioCyTASQ (Figure A).[14] Satisfyingly, these two TASQs displayed
similar G4-interacting properties, and the synthesis of BioCyTASQ
was more reliable than that of BioTASQ but remained time-consuming.
We thus sought an even shorter chemical access: inspired by reports
in which G4 ligands, in general,[15] and
a synthetic G-quartet, in particular,[16] were assembled by click chemistry, we decided to investigate the
design of new biotinylated TASQs. This was further motivated by the
description of possible beneficial effects of the triazole rings on
the G-quartet stability, further discussed hereafter.[16] We thus report here on two clicked TASQs, TriazoTASQ and
its biotinylated counterpart BioTriazoTASQ (Figure C), for which syntheses are indeed temporally
improved by click chemistry as compared to CyTASQ and BioCyTASQ, respectively,
with an overall similar efficiency. We then used the latter to visualize
G4s by a cellular imaging method referred to as pretargeted G4 imaging
and to provide insights into the ability of ligand-stabilized G4s
to trigger genetic instability, uniquely colocalizing G4 and DNA damage
sites in human cells by a combination of optical detection techniques.
Design,
Synthesis, and Evaluations of TriazoTASQ
The
design of TASQs was rethought using the copper(I)-catalyzed azide–alkyne
cycloaddition (CuAAC) of an alkynylated PNAG derivative
with an azido-substituted cyclen template. This reaction, initially
developed by Meldal et al.(17) and Sharpless et al.(18) and now commonly referred to as click chemistry, enables the coupling
of two reagents through the formation of a 1,4-disubstituted-1,2,3-triazole.
In our hands, the applicability of CuAAC was first checked with a
derivative of the commercially available cyclen, which led to TriazoTASQ
(Figure C).This nonbiotinylated TriazoTASQ was synthesized to both validate
this novel chemical pathway and assess whether these important structural
modifications affect the G4-interacting properties of the resulting
TASQ. 5-Azidopentyl mesylate, previously prepared in two steps from
the commercially available 5-aminopentan-1-ol in a 42% chemical yield,
was reacted with cyclen to afford the azido-substituted cyclen 1 with 25% yield (Supporting Information, Figures S1–S7). The alkynylated PNAG 2 was prepared from the commercially available Boc-PNAG-OH with 47% yield. After optimization (detailed in Figure S1), these two reagents were then coupled
using tetrakis(acetonitrile)copper(I) hexafluorophosphate ((CH3CN)4CuPF6) as the copper source and
tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine
(TBTA) used as a copper(I) chelator to afford the (Boc)4TriazoTASQ.Cu(II) complex with 23% yield. It is noteworthy that the
cyclen was found to efficiently chelate copper in these conditions,
requiring the use of an excess (1.5 mol equiv) of copper salt. After
demetalation with sodium sulfide (Na2S, quantitative yield)[19] and deprotection of the Boc groups with trifluoroacetic
acid (TFA, quantitative yield), TriazoTASQ was obtained in a satisfactory
chemical yield (2% yield over the longest, six-step branch of the
convergent synthesis; 11% yield over the shortest, four-step branch, Figures S2–S7).The apparent affinity
of TriazoTASQ for both G4-DNA and -RNA was
evaluated by Förster resonance energy transfer (FRET)-melting
assay using biologically relevant G4-forming sequences (Table ):[20] the G-rich DNA sequences found in the promoter regions of Myc gene
(F-Myc-T)[21] and at the human telomeres
(F21T);[22] the G-rich RNA sequences found
in the 5′-UTR (untranslated region) of the human neuroblastoma
RAS oncogene mRNA (F-NRAS-T) and of the human telomeric transcript
(F-TERRA-T);[23,24] along with a duplex-forming sequence
(F-duplex-T) as control. As seen in Figure A and Table , these results showed that the extra G4 thermal stability
induced by TriazoTASQ (expressed as an increase of the midtransition
temperature, ΔT1/2, in °C)
was improved as compared to that induced by the parent compound CyTASQ
(+23 to +209%). These results were thus in line with the positive
effect of the presence of a ring of four triazoles in the close proximity
to the synthetic G-quartet described with RAFT-based TASQ.[16] Both TriazoTASQ and CyTASQ were found to be
equally selective over duplex-DNA, as demonstrated by the lack of
interaction with F-duplex-T (ΔT1/2 < 0.1 °C for both TASQs). This was confirmed by competitive
FRET-melting experiments performed with an excess (50 mol equiv) of
a 17 bp duplex-DNA (ds17, Table ), with selectivity factors FRETS (calculated as FRETS = ΔT1/2(+50 mol-equiv-ds17)/ΔT1/2(no-competitor)) of 0.77 and 0.87
with F-Myc-T and F-TERRA-T, respectively, where FRETS tends to 1 with selectively (Figure S14).
Table 1
Non-, Mono-, and Dual-Labeled Oligonucleotides
Used in This Study
experiment
nature
name
sequence
FRET-melting assay
DNA
F21T
FAM-d[5′GGGTTAGGGTTAGGGTTAGGG3′]-TAMRA
F-Myc-T
FAM-d[5′GAGGGTGGGGAGGGTGGGGAAG3′]-TAMRA
F-duplex-T
FAM-d[5′TATAGCTATATTTTTTTATAGCTATA3′]-TAMRA
ds17 (comp.)
strand 1: d[5′CCAGTTCGTAGTAACCC3′]
strand 2: d[5′GGGTTACTACGAACTGG3′]
RNA
F-TERRA-T
FAM-r[5′GGGUUAGGGUUAGGGUUAGGG3′]-TAMRA
F-NRAS-T
FAM-r[5′GGGAGGGGCGGGUCUGGG3′]-TAMRA
fluorescence pull-down assay
DNA
F-22AG
FAM-d[5′AGGGTTAGGGTTAGGGTTAGGG3′]
F-Myc
FAM-d[5′GAGGGTGGGGAGGGTGGGGAAG3′]
F-duplex
FAM-d[5′TATAGCTATATTTTTTTATAGCTATA3′]
RNA
F-TERRA
FAM-r[5′GGGUUAGGGUUAGGGUUAGGG3′]
F-NRAS
FAM-r[5′
GGGAGGGGCGGGUCUGGG 3′]
Figure 2
(A) FRET-melting results (ΔT1/2, °C, n = 3) for experiments performed
with
TriazoTASQ, BioCyTASQ, and BioTriazoTASQ (1 μM, 5 mol equiv)
and the G4-DNA F-Myc-T and F21T, the G4-RNA F-NRAS-T and F-TERRA-T,
and the control F-duplex-T (0.2 μM). (B) Fluorescence pull-down
results (FAM fluorescence enhancement, fold-change, n = 3) for experiments performed with biotin, BioCyTASQ, and BioTriazoTASQ
(10 μM, 10 mol equiv) and the G4-DNA F-Myc and F-22AG, the G4-RNA
F-NRAS and F-TERRA, and the control F-duplex (1 μM). (C) qPCR
pull-down results (SYBR green fluorescence intensity, n = 3) for experiments performed without molecule (control) or with
biotin, BioCyTASQ, and BioTriazoTASQ (40 μM, 10 mol equiv) and
the G4-strand (4 μM). (D) Schematic representation of TriazoTASQs
in interaction with G4s used for FRET-melting and pull-down assays.
Table 2
Results of FRET-Melting and Pull-Down
Assays Performed with TASQs
FRET-melting assay (ΔT1/2, °C)
G4-DNA
duplex-DNA
G4-RNA
F-Myc-T
F21T
F-duplex-T
F-NRAS-T
F-TERRA-T
CyTASQa
8.7 ± 0.7
5.2 ± 0.4
0.1 ± 0.1
4.4 ± 0.4
10.0 ± 0.1
TriazoTASQ
18.6 ± 0.5
6.4 ± 1.1
–0.2 ± 2.0
13.6 ± 0.5
15.8 ± 2.5
BioCyTASQ
16.3 ± 1.5
3.9 ± 0.7
–0.1 ± 1.2
13.2 ± 1.9
11.2 ± 1.9
BioTriazoTASQ
12.6 ± 0.3
2.7 ± 0.3
–0.2 ± 0.9
12.4 ± 0.4
9.9 ± 1.8
From ref (14).
(A) FRET-melting results (ΔT1/2, °C, n = 3) for experiments performed
with
TriazoTASQ, BioCyTASQ, and BioTriazoTASQ (1 μM, 5 mol equiv)
and the G4-DNA F-Myc-T and F21T, the G4-RNA F-NRAS-T and F-TERRA-T,
and the control F-duplex-T (0.2 μM). (B) Fluorescence pull-down
results (FAM fluorescence enhancement, fold-change, n = 3) for experiments performed with biotin, BioCyTASQ, and BioTriazoTASQ
(10 μM, 10 mol equiv) and the G4-DNA F-Myc and F-22AG, the G4-RNA
F-NRAS and F-TERRA, and the control F-duplex (1 μM). (C) qPCR
pull-down results (SYBR green fluorescence intensity, n = 3) for experiments performed without molecule (control) or with
biotin, BioCyTASQ, and BioTriazoTASQ (40 μM, 10 mol equiv) and
the G4-strand (4 μM). (D) Schematic representation of TriazoTASQs
in interaction with G4s used for FRET-melting and pull-down assays.From ref (14).
Design, Synthesis, and Evaluations of BioTriazoTASQ
With the TriazoTASQ scaffold being validated, we next designed BioTriazoTASQ,
for which the synthetic scheme (Figures C and S8–S13) was directly inspired by that of TriazoTASQ, starting from the
noncommercially available aminomethylcyclene (AMC).[25] This template was first coupled to biotin (32% yield) and
then reacted with 5-azidopentyl mesylate as above to afford compound 3 in 37% yield. Next, the CuAAC with 2 afforded
the (Boc)4BioTriazoTASQ.Cu(II) complex (23% yield) which
was subsequently demetalated (Na2S, quantitative) and deprotected
(TFA, quantitative). BioTriazoTASQ was obtained in a lower overall
chemical yield than BioCyTASQ (3% versus 5% yield, respectively, for
five steps in both instances) but in a shorter manner (54 h versus
126 h for BioTriazoTASQ and BioCyTASQ, respectively).As above,
the apparent G4 affinity of BioTriazoTASQ was assessed by FRET-melting
experiments performed with G4-DNA (F-Myc-T and F21T), G4-RNA (F-NRAS-T
and F-TERRA-T), and control F-duplex-T. The G4 stabilization induced
by BioTriazoTASQ was decreased as compared to the parent compound
BioCyTASQ, more markedly with G4-DNA (−23 and −31%,
respectively, Figure A, Table ) than with
G4-RNA (−9 to −11%). These results indicated that the
presence of the triazoles near the synthetic G-quartet did not further
improve G4-binding in the biotinylated series, with the initial G4-stabilizing
properties of BioCyTASQ being good and better than that of CyTASQ
(with the notable exception of the polymorphic F21T). Satisfyingly,
the G4-selectivity of BioTriazoTASQ remained very high (ΔT1/2 < 0 °C with F-duplex-T; FRETS > 0.87, Figure S14),
which thus made it a good candidate for G4 pull-down protocols.This was first investigated through a fluorescence-based affinity
capture protocol developed for BioCyTASQ.[14] Briefly, the oligonucleotides used for FRET-melting assays were
used labeled by FAM only (F-Myc, F-22AG, F-duplex, F-NRAS, and F-TERRA, Table ); these oligonucleotides
were incubated (1 μM) for 1.5 h at room temperature with either
BioCyTASQ or BioTriazoTASQ (10 μM, along with biotin as a control)
in the presence of streptavidin-coated magnetic beads. Then, the complexes
of nucleic acids/TASQ/beads were magnetically immobilized, the supernatant
removed, and the FAM-labeled DNA/RNA was resuspended in solution after
a thermal denaturation step (8 min at 90 °C). The capture efficiency
of the two TASQs was quantified by the FAM emission of the resulting
solution (normalized to the control performed without TASQ).As seen in Figure B and Table , both
BioCyTASQ and BioTriazoTASQ efficiently capture G4s albeit with a
noticeable discrepancy, as BioCyTASQ was found more efficient with
G4-DNA (ca. 19 and 16-fold enrichment with F-Myc
and F-22AG, respectively, versus ca. 7- and 5-fold
for BioTriazoTASQ) while BioTriazoTASQ was more efficient with G4-RNA
(ca. 13- and 7-fold enrichment with F-NRAS and F-TERRA, versus ca. 4- and 3-fold for BioCyTASQ, a trend confirmed
with another G4-RNA, F-TRF2, Figure S15). One hypothesis to explain the preferential interaction of BioTriazoTASQ
with G4-RNA could be that the stacking interaction between the triazole
ring and the intramolecular G-quartet brings them closer and pushes
the connecting linkers outward. This would make the TASQ’s
quartet more sterically demanding, which thus could drive the interaction
toward G4-RNA, as their external G-quartet is more accessible than
that of the G4-DNA. To investigate this, a series of molecular dynamics
(MD) simulations were undertaken with CyTASQ and TriazoTASQ (Figure S16): these calculations did not confirm
the coplanar assembly of the triazoles but indicated that (i) TriazoTASQ
is more sterically demanding than CyTASQ (solvent-accessible surface
area = 21.4 versus 18.5 nm2) and (ii) the nature of the
guanine arms does influence the steric hindrance of external G-quartet,
with that of CyTASQ being hindered by surrounding amide connectors
while that of TriazoTASQ being more freely accessible (further discussed
in the Supporting Information). These subtle
differences might thus be responsible for the differential recognition
of DNA/RNA G4s. Finally, both TASQs were enticingly selective, as
none of them captured F-duplex, which was further confirmed by competitive
experiments performed with an excess (25 mol equiv) of a nucleic acid
mixture (calf thymus DNA, or CT-DNA), with selectivity factor S > 0.94 (Figure S15).To go a step further, we investigated the G4-capturing ability
of both TASQs in more biologically relevant conditions. To this end,
we incorporated a G4-forming sequence into a long DNA strand (97-nt
long, d[N41-G3(CAG3)3-N38]),[26] devoid of fluorescent tags,
which made its detection possible only through qPCR analysis. This
new protocol was performed with BioCyTASQ and BioTriazoTASQ (Figure C), along with two
control experiments performed without TASQ (for the nonspecific binding
of oligonucleotides on beads) and with biotin. The protocol thus comprised
an incubation of the DNA (4 μM) without or with TASQ/biotin
(40 μM, 10 mol equiv) in the presence of the streptavidin-coated
magnetic beads for 2 h at room temperature, followed by magnetic immobilization
of DNA/TASQ/beads and release of captured DNA (thermal denaturation)
prior to qPCR amplification (expressed as SYBR Green fluorescence
intensity, or FI). In these conditions, both BioCyTASQ and BioTriazoTASQ
showed good efficiency to capture G4 (ΔFI = 718.4 and 608.3,
respectively, when compared to the experiment performed without TASQ, Figure C), thus confirming
their suitability for being used as molecular bait for G4s embedded
in long nucleic acid sequences.
Pretargeted Optical Imaging
Reveals G4-Mediated DNA Damage Sites
We already showed that
biotinylated TASQs can also be used to track
and detect G4s in human cells due to a pretargeted imaging protocol
using the fluorescently labeled streptavidin Cy3-SA (schematically
represented in Figures A).[14] To go a step further, we decided
to implement this protocol to demonstrate that G4s can act as roadblocks
to polymerases, thereby creating a crisis situation recognized as
a DNA damage.[27,28] The propensity of G4s to trigger
DNA damage when stabilized by ligands such as PDS and CX-5461 is firmly
documented.[29−32] This is commonly shown by a G4 ligand-promoted increase in antibody
labeling the most lethal form of DNA damage, the double strand breaks
(DSBs), by either the phosphorylated histone γH2AX[33,34] or tumor suppressor p53 binding protein 1 (53BP1).[35] Direct demonstrations of the colocalization of G4 and DNA
damage sites are sparse in the literature, including the concomitant
immunodetection of DSBs and G4s using the G4-specific BG4[36] in combination anti-γH2AX (upon incubation
with PDS)[37] or anti-53BP1 antibodies (incubation
with CM03),[38] and a combination of the
anti-G4 1H6[39] with anti-γH2AX (incubation
with PDS)[40] or anti-53BP1 antibodies (incubation
with EMICORON).[41] While most of these observations
were qualitative in nature, Neidle et al. provided
a quantitative analysis of the BG4/anti-53BP1 colocalization,[38] showing that 1.4% of the BG4 foci (ca. 400 foci/nucleus) were associated
with DNA damage (ca. 20 53BP1 foci/nucleus).
Figure 3
(A) Schematic representation of the TASQ-stabilized G4-mediated
DNA damage and related signaling pathway used to colocalize G4 and
DNA damage sites (of note, the primary, anti-γH2AX antibody
is removed for clarity). (B) High-resolution optical images of MCF7
cells treated with BioTriazoTASQ (1 μM, 24 h), tagged with Cy3-SA
(green) after cell fixation (scale bar = 10 μm), which is followed
by immunodetection of DNA damage foci (γH2AX,
red) and chromatin staining by DAPI (blue). Inset and arrows highlight
of the nucleoplasmic sites where both DSBs and TASQ colocalize. (C,D)
Automated (C) or manual (D) quantification of γH2AX foci/cell, with or without TASQ treatment, and of the overlaps
between green (TASQ) and red signals (γH2AX). (E) Modulation
of the γH2AX, BioTriazoTASQ and common foci upon incubation of MCF7 cells by PDS (5 μM, 6 h) and G4-labeling
by BioTriazoTASQ (used after cell fixation; 10 μM, overnight)
and Cy3-SA. Statistics: p-values, *p < 0.05, **p < 0.01, and ***p < 0.001.
(A) Schematic representation of the TASQ-stabilized G4-mediated
DNA damage and related signaling pathway used to colocalize G4 and
DNA damage sites (of note, the primary, anti-γH2AX antibody
is removed for clarity). (B) High-resolution optical images of MCF7
cells treated with BioTriazoTASQ (1 μM, 24 h), tagged with Cy3-SA
(green) after cell fixation (scale bar = 10 μm), which is followed
by immunodetection of DNA damage foci (γH2AX,
red) and chromatin staining by DAPI (blue). Inset and arrows highlight
of the nucleoplasmic sites where both DSBs and TASQ colocalize. (C,D)
Automated (C) or manual (D) quantification of γH2AX foci/cell, with or without TASQ treatment, and of the overlaps
between green (TASQ) and red signals (γH2AX). (E) Modulation
of the γH2AX, BioTriazoTASQ and common foci upon incubation of MCF7 cells by PDS (5 μM, 6 h) and G4-labeling
by BioTriazoTASQ (used after cell fixation; 10 μM, overnight)
and Cy3-SA. Statistics: p-values, *p < 0.05, **p < 0.01, and ***p < 0.001.Surprisingly, examples of the
concomitant use of a G4 probe and
a DNA damage marker are even sparser, chiefly, a qualitative example
involving a combination of a naphthalene diimide (NDI) and anti-γH2AX
antibody.[42] To provide a quantitative analysis,
we treated MCF7 cells with either BioCyTASQ or BioTriazoTASQ (1 μM,
24 h; IC50 > 100 μM) before fixation with cold
MeOH
(5 min) followed by cell permeabilization and sequential incubation
(in a dark chamber) with SA-Cy3 (1 μg/mL, 1 h), γH2AX-specific
antibody (1/2000, 2 h), fluorophore-labeled secondary antibody (IgG-AF647,
1/500, 45 min) and DAPI (1 μg/mL, 5 min). The collected images
(Figures B, S17, and S18) indicate
first that live incubation of MCF7 cells with a subtoxic concentration
of TASQs triggered a slight induction of DNA damage, quantified as
the average number of γH2AX foci per cell (ca. 5.3 foci/nucleus for TASQ-treated cells,
versus 4.0 foci/nucleus for untreated cells, >160
cells/conditions (n = 3), Figures C).To make this analysis straightforward
and reliable, we developed
an automated image processing FIJI macro for foci quantification (the
script is provided in the Supporting Information, and the macro is downloadable). This analysis led to the quantification
of colocalized Cy3-SA-tagged TASQ and γH2AX sites, with approximately
4.0 and 4.9% of the BioCyTASQ- and BioTriazoTASQ-labeled foci overlapping
with γH2AX foci (insets in Figure B; Figure C). The reliability and accuracy of the automatic scoring
was verified by manual scoring (on ca. 30% of the
samples, i.e., 600 cells analyzed): it was found
that 2.7 and 2.9% of the BioCyTASQ- and BioTriazoTASQ-labeled foci
overlapped with γH2AX foci (Figure D), which is yet lower than that of the automatized
count (which depends on the number of analyzed cells but also on the
selected thresholds) but in a close range. Globally, these low percentages
originate in the weak ability of TASQ to induce DNA damage (ca. 5 foci/cell, + 33% increase as compared to untreated
cells); however, they are higher than the common BG4/53BP1 sites described
above, which results from the far lower number of G4 sites detected
by TASQ (ca. 30 foci/nucleus) than by BG4 (ca. 400 foci/nucleus, i.e., 23-fold more),
which has to be compared to the 4-fold difference (only) in damage
site count (ca. 5 γH2AX versus 20 53BP1 foci/nucleus).
In order to increase the number of DNA damage sites, cells were preincubated
with PDS (5 μM, 6 h), which indeed resulted in a raise of the
number of γH2AX foci (1.5-fold, Figures E and S19). To
avoid competition between the two ligands (PDS and TASQ) for the cellular
G4 targets, BioTriazoTASQ was used here as a postfixation agent (10
μM, overnight): despite a slight decrease of the number of TASQ
foci (0.9-fold), the number of common TASQ/γH2AX foci significantly
increased (1.9-fold), which indicates both the suitability of this
approach to the study of G4-targeting DNA damaging agents and the
versatility of TASQ that can be used either in live cells or after
cell fixation. Altogether, these results provided a direct demonstration
that ligand-stabilized G4 sites can indeed colocalize with DSBs in
cells.In conclusion, this wealth of data continues to demonstrate
the
interest of versatile and multivalent molecular tools for chemical
biology investigations, in general, and of biomimetic, TASQ-based
G4 ligands for G4-focused research, in particular. The biotinylated
TASQ used here can indeed be implemented in various in vitro manipulations (affinity capture, optical imaging) to sharpen our
knowledge about G4 biology. The technicality of TASQs is in considering
their chemical access, that we have tried to improve here by using
click chemistry for the key conjugation step between the PNAG units and the cyclen-based template. Overall, this strategy turned
out to be synthetically advantageous and also revealed that changes
to the TASQ scaffold result in a subtle modification of the G4-interacting
properties of the resulting TASQs, as exemplified by the differential
ability to pull down G4-DNA (BioCyTASQ) or G4-RNA (BioTriazoTASQ).
We are currently further investigating the possible origins of this
observation, as many parameters, not easily disentangled (including
the molecular volume and flexibility, the accessibility of the external
G-quartet), have to be taken into account. However, this empirical
observation is important as it may guide the selection of the most
suited candidate in our growing portfolio of TASQs as a function of
the intended application.
Methodology
Cell Culture
MCF7 cells were routinely cultured in
75 cm2 tissue culture flasks at 37 °C in a humidified,
5% CO2 atmosphere in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin
(5.0 U mL–1 pen/5.0 μg mL–1) mixture. Cells were subcultured twice a week using standard protocols.
Pretargeted G4 Imaging
Round coverslips (12 mm) were
sterilized with 70% ethanol before cell seeding. MCF7 cells were seeded
at a density of 6 × 104 cells per coverslip on chambered
coverslips (24-well plate) and allowed to recover overnight. Cells
were incubated with either BioCyTASQ or BioTriazoTASQ (1 μM,
24 h) at 37 °C, washed once with PBS 1×, fixed and permeabilized
with cold MeOH for 5 min at –20 °C, washed with PBS 1×
(3 × 5 min), then incubated with (1) blocking buffer (PBS 1X/BSA
1%/Triton X-100 0.1%, 10 min at 25 °C); (2) streptavidin-Cy3
(ThermoFisher Scientific 434315, 1 μg/mL, 1 h); (3) PBS 1×/Triton
X-100 0.1% (3 × 5 min); (4) anti-γH2AX antibody (Merck
Millipore 05-636, mouse monoclonal Ab, 1/2000, 2 h in dark chamber);
(5) PBS 1×/Triton X-100 0.1% (3 × 5 min); (6) anti-mouse
Ig-AF647 antibody (donkey, 1/500, 45 min in dark chamber); (7) PBS
1×/Triton X-100 0.1% (3 × 5 min); (8) DAPI (1 μg/mL,
5 min in dark chamber); and (9) PBS 1× (3 × 5 min). Cells
were mounted and imaged with a confocal laser-scanning microscope
with a 63× oil objective, collected through the following channels:
DAPI (emission 448–475 nm), AF647 (emission 644–696
nm), and Cy3 (emission: 558–575 nm).
Image Processing
Images were processed with ImageJ
(https://fiji.sc); for statistical
hypothesis tests, Student’s t-test and Welch’s
unequal variances t-test were used depending on variances
equality. The automated foci quantification was made
according to homemade FIJI add-ons, which can be download (free of
charge) at https://github.com/ICMUB/TASQ/blob/main/macro-eng_quantif-foci-int_TASQ-gH2AX.ijm
Authors: Isaline Renard; Michael Grandmougin; Apolline Roux; Sunny Y Yang; Pauline Lejault; Marc Pirrotta; Judy M Y Wong; David Monchaud Journal: Nucleic Acids Res Date: 2019-06-20 Impact factor: 16.971
Authors: Wei Ting C Lee; Yandong Yin; Michael J Morten; Peter Tonzi; Pam Pam Gwo; Diana C Odermatt; Mauro Modesti; Sharon B Cantor; Kerstin Gari; Tony T Huang; Eli Rothenberg Journal: Nat Commun Date: 2021-05-05 Impact factor: 14.919